Table 3.
Dynamics of complaint rates in patients who have had COVID
| At the beginning of treatment, % | At the end of the treatment, % | Asymptotic significance | |
|---|---|---|---|
| Paleness of skin | 2 | 2 | 1 |
| Skin moisture content | 3 | 3 | 1 |
| Dry mouth | 20 | 8* | 0,063 |
| Reduced muscle mass | 2 | 2 | 0,48 |
| Weakness | 26 | 14* | 0,014 |
| Increased systolic pressure | 16 | 5* | 0,043 |
| Nausea | 1 | 1 | 1 |
| Vomiting | 0 | 0 | 1 |
Data are presented as frequencies. The analysis of differences was made according to the X2 criterion. *, significant improvement